AMGN Amgen
- 308.290
- -1.860-0.60%
Amgen News
The Zacks Analyst Blog Highlights Amgen, Amazon.com, Apple, Boeing and Goldman Sachs
Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating
Amgen (AMGN) has an average rating of outperform and price targets ranging from $170 to $380, according to analysts polled by Capital IQ. Price: 309.75, Change: -0.40, Percent Change: -0.13
5 Stocks Driving Dow's Market-Beating Performance
The Dow Jones Industrial Average emerged stronger than the other two major indices in the latest market rally, driven by renewed hopes of rate cuts, solid corporate earnings and increased stock buybacks.
Amgen (NASDAQ:AMGN) Investors Are up 12% in the Past Week, but Earnings Have Declined Over the Last Five Years
If you want to compound wealth in the stock market, you can do so by buying an index fund. But in our experience, buying the right stocks can give your wealth a significant boost. For example, the A
“Weight loss elixir” is popular all over America! Research shows that 1 in 8 people have used it
More than half of those who have tried weight loss injections say it is difficult for them to afford them one after another; health insurance has not made these drugs more affordable, according to a survey.
Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps.
The two companies will also work on a shot that combines Covid-19 and flu vaccines.
Drugmakers in Medicare Price Negotiations Spent Less on Research Than on Shareholder Payments, Marketing and Overhead: Report
Trade Desk To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Baird raise
Amgen Is Maintained at Neutral by Mizuho
Amgen Is Maintained at Neutral by Mizuho
Mizuho Bank: Maintaining the Amgen (AMGN.US) rating, adjusted from neutral to neutral, and adjusted the target price from $223.00 to $235.00.
Mizuho Bank: Maintaining the Amgen (AMGN.US) rating, adjusted from neutral to neutral, and adjusted the target price from $223.00 to $235.00.
Mizuho Maintains Neutral on Amgen, Raises Price Target to $235
Mizuho analyst Salim Syed maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $223 to $235.
Amgen Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 -23.57% Mizuho $223 → $235 Maintains Neutral 05/03/2024 6.67% RBC Capital $332 → $328 Maintains
Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170
Amgen (AMGN) has an average outperform rating and a price target range of $170 to $380, according to analysts polled by Capital IQ.
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
THOUSAND OAKS, Calif., May 9, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:20 a.m. PT on Tuesday, May 14, 2024. Peter Gr
Mizuho Securities Raises Amgen's Price Target to $235 From $223
Amgen (AMGN) has an average outperform rating and a price target range of $170 to $380, according to analysts polled by Capital IQ. Price: 304.24, Change: +3.94, Percent Change: +1.31
Market Whales and Their Recent Bets on AMGN Options
Whales with a lot of money to spend have taken a noticeably bearish stance on Amgen.Looking at options history for Amgen (NASDAQ:AMGN) we detected 17 trades.If we consider the specifics of each trade,
Is the “Nolly” monopoly myth changing? Pharmaceutical companies frequently introduce new drugs, and “weight loss duos” face challenges
Novo Nordisk and Eli Lilly's dominance in the emerging diet medicine market could eventually be threatened by strong rivals.
15 Best S&P 500 Dividend Stocks To Buy Now
How Is The Market Feeling About Amgen?
Amgen's (NYSE:AMGN) short percent of float has fallen 3.57% since its last report. The company recently reported that it has 10.11 million shares sold short, which is 1.89% of all regular shares that
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Analysis
Price Target
No Data
